GNAO1 and Dystonia: A therapeutic trial with levodopa was started, with improvement of dystonia.<h4>Discussion</h4>GNAO1 gene variant disorders share similarities with other causes of CP syndrome, and thus investigation of this variant should be included in instances of CP syndrome without a clear history of previous perinatal brain injury.